DevalingamMahalingamMD

Clinical Trials

• Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma Start of enrollment: 2009 Sep 01

  Completed

  Phase 2

• A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma Start of enrollment: 2009 Oct 01

  Completed

  Phase 2

• Hydroxychloroquine + Vorinostat in Advanced Solid Tumors Start of enrollment: 2009 Nov 01

  Completed

  Phase 1

• Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors Start of enrollment: 2010 Jan 01

  Completed

  Phase 1

• Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma Start of enrollment: 2013 Apr 01

  Completed

  Phase 1, Phase 2

• A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer Start of enrollment: 2012 Sep 01

  Completed

  Phase 1, Phase 2

• Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer Start of enrollment: 2011 Apr 01

  Completed

  Phase 2

• Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma Start of enrollment: 2013 Jan 01

  Completed

  Phase 2

• A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm Start of enrollment: 2013 Jul 01

  Completed

  Phase 1

• A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Start of enrollment: 2014 May 05

  Completed

  Phase 1

• Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma

  No longer available

• Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer Start of enrollment: 2017 Feb 16

  Recruiting

  Phase 2

• Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 Start of enrollment: 2019 Jan 29

  Active, not recruiting

  Phase 2

• Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer Start of enrollment: 2018 Nov 14

  Terminated

  Phase 2

• 9-ING-41 in Patients With Advanced Cancers Start of enrollment: 2019 Jan 04

  Active, not recruiting

  Phase 2

  Roles: Contact

• CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors Start of enrollment: 2023 Mar 08

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Join now to see all